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Abstract: In this case report, we describe a case of isolated oculomotor nerve palsy associated 
with antibodies to mitotic spindle apparatus (anti-MSA). A 28-year-old female patient had acute, 
painful vertical diplopia. She had limited depression and adduction in the right eye. There was 
no relative afferent pupillary defect. Brain magnetic resonance imaging showed no abnormal 
findings. Laboratory tests were all negative, with the exception of positive anti-MSA, She had 
an excellent and rapid response to treatment with corticosteroids, and completely recovered 
after two weeks of steroid pulse therapy.
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Introduction
The causes of isolated oculomotor nerve palsy have been documented in various 
  diseases. Most cases of isolated third nerve palsy are attributable to disease states that 
affect the vascular system, including diabetes mellitus and hypertension.1 However, 
we must carefully consider other causes in young patients without vasculopathic risk 
factors. Multiple sclerosis, Sjogren’s syndrome, antiphospholipid syndrome, and leu-
kemia involving the central nervous system are rarely reported as causes of isolated 
oculomotor nerve palsy,2,3 but oculomotor nerve palsy associated with antibodies 
to mitotic spindle apparatus (anti-MSA, an auto-antinuclear antibody) has not been 
reported to date. We describe a patient with isolated oculomotor nerve palsy associ-
ated with anti-MSA.
Case report
A 28-year-old woman suddenly developed painful vertical diplopia. She had been 
  suffering from a cold for one week. She had no significant contributory past history 
and no systemic diseases, such as diabetes mellitus, hypertension, or coagulopathy. 
A full ophthalmologic examination was performed. Her best corrected visual acu-
ities were 20/25 in the right eye and 20/30 in the left eye. Alternate cover prism test 
revealed 10 prism diopters of hypertropia in the right eye. She had limited depression 
and adduction in the right eye as well (Figure 1). The forced duction test was negative. 
There was no relative afferent pupillary defect.
We performed laboratory tests, including a complete blood cell count, erythro-
cyte sedimentation rate, C-reactive protein, rheumatoid factor, antinuclear antibod-
ies, antineutrophil cytoplasm antibodies, and serologic tests for viral markers. We 
also performed a chest x-ray and brain magnetic resonance imaging. The laboratory Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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findings were unremarkable, with the exception of positive 
rheumatoid factor (titer 1:320) and antinuclear antibody 
(mitotic spindle fiber type, titer 1:620). Brain magnetic 
resonance imaging with gadolinium enhancement revealed 
no abnormal findings.
We believed that the patient had pupil-sparing incomplete 
third nerve palsy (mainly involving the inferior division) 
related to autoimmune disease, so admitted her and treated 
her with intravenous methylprednisolone 250 mg four times 
daily for three days, and tapered the steroid thereafter. Her 
extraocular movements resolved completely at two weeks 
after steroid pulse therapy. The last follow-up visit was per-
formed six weeks after the initiation of steroid pulse therapy. 
During the follow-up period, she manifested no significant 
neurological sequelae.
Discussion
Anti-MSA antibodies are not associated with a defined auto-
immune pathology, but some studies have reported anti-MSA 
in the sera of patients with connective tissue diseases, infec-
tions, autoimmune hepatitis, vasculitis, primary antiphospho-
lipid syndrome, malignancy, and fever of unknown origin.4,5 
The aforementioned autoimmune diseases are well associated 
with oculomotor nerve palsy. However, the present report is 
the first reported case of a patient with isolated oculomotor 
nerve palsy associated with anti-MSA. The mitotic spindle 
apparatus is a unique structure of microtubules and associated 
proteins involved in the segregation and reorganization of 
chromosomes during cell division. Anti-MSA is identified 
during the immunofluorescent detection of antinuclear anti-
bodies, which are associated with autoimmune diseases.6,7
There are two possible mechanisms related to this cranial 
neuropathy with autoimmune diseases, namely “vascular” 
(due to damage of the vasa nervorum) or an “immunologic 
cause” (due to lymphocytic infiltration of the nerve).8 The 
patient had an excellent and rapid response to intravenous 
methylprednisolone treatment and completely recovered 
two weeks after the start of steroid pulse therapy. Therefore, 
lymphocytic infiltration or autoantibodies to components of 
the cranial nerves might play an important role. Lui et al2 
also reported on a patient with unilateral oculomotor nerve 
palsy and Sjogren’s syndrome who experienced an almost 
complete recovery of both ptosis and diplopia after two weeks 
of treatment, and an immunologic neuropathic process was 
thought to be the cause.
In conclusion, although oculomotor nerve paralysis is 
usually believed to be self-limiting, steroid pulse therapy 
should be considered in cases of ocular paralysis when 
Figure 1 Nine cardinal directions of gaze showing exodeviation, limitation of adduction, and infraduction in the right eye at initial visit.Clinical Ophthalmology
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other possible causes, such as autoimmune disease, have 
been excluded.
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